» Articles » PMID: 12745064

Molecular Characterisation of Six Alternatively Spliced Variants and a Novel Promoter in Human Peroxisome Proliferator-activated Receptor Alpha

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2003 May 15
PMID 12745064
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxisome proliferator-activated receptor alpha (PPARalpha) is a ligand-activated transcriptional factor that governs many biological processes, including lipid metabolism, inflammation, and atherosclerosis. We demonstrate here the existence of six variants and multiple transcriptional start sites of the 5(') untranslated region (UTR) of hPPARalpha gene, originating from the use of alternative splicing mechanisms and four different promoters. Three new novel exons at the 5(')-untranslated region of human PPARalpha gene were also identified and designated as Exon A, Exon B, and Exon 2b. In addition, 1.2kb promoter fragment which drives the transcription of 2 variants with Exon B (hPPARalpha4 and 6) was successfully cloned and characterised. Sequencing results revealed promoter B did not contain a conservative TATA box within the first 100 nucleotides from transcriptional start site but has several GC-rich regions and putative Sp1 sites. Using luciferase reporter constructs transfected into HepG2 and Hep3B cell lines, promoter B was shown to be functionally active. Basal transcriptional activity was significantly high in the promoter fragment -341/+34, but lower in the region -341/-1147 as compared to the fragment -341/+34, indicating the presence of an element conferring transcriptional activation between positions -341 and +34 or alternatively, the presence of transcriptional repression between positions -341 and -1147 in the promoter B of hPPARalpha.

Citing Articles

Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primates.

Swanson C, Emborg M Neurol Res. 2014; 36(7):634-46.

PMID: 24620964 PMC: 4254814. DOI: 10.1179/1743132813Y.0000000305.


Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells.

Chew G, Myers S, Shu-Chien A, Tengku Muhammad T Mol Cell Biochem. 2013; 388(1-2):25-37.

PMID: 24242046 DOI: 10.1007/s11010-013-1896-z.


Tissue-specific 5' heterogeneity of PPARα transcripts and their differential regulation by leptin.

Garratt E, Vickers M, Gluckman P, Hanson M, Burdge G, Lillycrop K PLoS One. 2013; 8(6):e67483.

PMID: 23825665 PMC: 3692471. DOI: 10.1371/journal.pone.0067483.


Rare PPARA variants and extreme response to fenofibrate in the Genetics of Lipid-Lowering Drugs and Diet Network Study.

Irvin M, Zhang Q, Kabagambe E, Perry R, Straka R, Tiwari H Pharmacogenet Genomics. 2012; 22(5):367-72.

PMID: 22336959 PMC: 3325369. DOI: 10.1097/FPC.0b013e328351a486.


ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells.

Boergesen M, la Cour Poulsen L, Schmidt S, Frigerio F, Maechler P, Mandrup S J Biol Chem. 2011; 286(15):13214-25.

PMID: 21282101 PMC: 3075668. DOI: 10.1074/jbc.M110.215467.